Quốc gia: Ai-len
Ngôn ngữ: Tiếng Anh
Nguồn: HPRA (Health Products Regulatory Authority)
Ciclosporin
Novartis Ireland Limited
L04AD; L04AD01
Ciclosporin
100 milligram(s)
Capsule, soft
Product subject to prescription which may be renewed (B)
Calcineurin inhibitors; ciclosporin
Marketed
1988-03-21
1 PACKAGE LEAFLET: INFORMATION FOR THE PATIENT SANDIMMUN ® 25 MG SOFT CAPSULES SANDIMMUN ® 50 MG SOFT CAPSULES SANDIMMUN ® 100 MG SOFT CAPSULES ciclosporin READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See Section 4. WHAT IS IN THIS LEAFLET 1. What Sandimmun is and what it is used for 2. What you need to know before you take Sandimmun 3. How to take Sandimmun 4. Possible side effects 5. How to store Sandimmun 6. Contents of the pack and other information 1. WHAT SANDIMMUN IS AND WHAT IT IS USED FOR WHAT SANDIMMUN IS The name of your medicine is Sandimmun. It contains the active substance ciclosporin. This belongs to a group of medicines known as immunosuppressive agents. These medicines are used to lower the body’s immune reactions. WHAT SANDIMMUN IS USED FOR AND HOW SANDIMMUN WORKS • IF YOU HAVE HAD AN ORGAN TRANSPLANT, BONE MARROW AND STEM CELL TRANSPLANTATION , the function of Sandimmun is to control your body’s immune system. Sandimmun prevents rejection of transplanted organs by blocking the development of certain cells which would normally attack the transplanted tissue. • IF YOU HAVE AN AUTOIMMUNE DISEASE , in which your body’s immune response attacks your body’s own cells, Sandimmun stops this immune reaction. Such diseases include eye problems which threaten your vision (endogenous uveitis, including Behçet's uveitis), severe cases of certain skin diseases (atopic dermatitis, or eczema and psoriasis), severe rheumatoid arthritis and a kidney disease called nephrotic syndrome. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAK Đọc toàn bộ tài liệu
Health Products Regulatory Authority 28 June 2023 CRN00DP1V Page 1 of 18 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Sandimmun 100mg Soft Capsules 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each capsule contains 100 mg ciclosporin. Excipients with known effect: Ethanol: 100 mg/capsule. Sandimmun soft capsules contain 12.8% v/v ethanol (10.2% m/v). Sorbitol partially dehydrated: 103.8mg/capsule. For the full list of excipients see section 6.1. 3 PHARMACEUTICAL FORM Capsule, soft Dusty rose, oblong soft gelatin capsules 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Transplantation indications _Solid organ transplantation_ Prevention of graft rejection following solid organ transplantation. Treatment of transplant cellular rejection in patients previously receiving other immunosuppressive agents. _Bone marrow transplantation_ Prevention of graft rejection following allogeneic bone marrow and stem cell transplantation. Prevention or treatment of graft-versus-host disease (GVHD). Non-transplantation indications _Endogenous uveitis_ Treatment of sight-threatening intermediate or posterior uveitis of non-infectious aetiology in patients in whom conventional therapy has failed or caused unacceptable side effects. Treatment of Behçet uveitis with repeated inflammatory attacks involving the retina in patients without neurological manifestations. _Nephrotic syndrome_ Steroid-dependent and steroid-resistant nephrotic syndrome, due to primary glomerular diseases such as minimal change nephropathy, focal and segmental glomerulosclerosis, or membranous glomerulonephritis. Sandimmun can be used to induce and maintain remissions. It can also be used to maintain steroid-induced remission, allowing withdrawal of steroids. _Rheumatoid arthritis_ Treatment of severe, active rheumatoid arthritis. Health Products Regulatory Authority 28 June 2023 CRN00DP1V Page 2 of 18 _Psoriasis_ Treatment of severe psoriasis in patients in whom conventional therapy is inappropriate or ineffective. _Atopic dermatitis_ Sand Đọc toàn bộ tài liệu